• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform

    Diagnostic Desperation: A Look at IVD Trends During COVID-19

    Resourceful Resources: Materials Make a Difference During the Pandemic

    Stressed Testing: Challenges with Medical Device Testing
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA OKs First OTC Home Molecular COVID-19 Test

    FDA Approves Second Sight's Argus 2s Retinal Prosthesis

    Cross Border Venture Financing Rose in Final Quarter of 2020

    Aetna Executive Joins Inogen's Board of Directors

    Guided Therapeutics Raises $1.1 Million in New Preferred Stock Offering
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform

    Diagnostic Desperation: A Look at IVD Trends During COVID-19

    Resourceful Resources: Materials Make a Difference During the Pandemic

    Stressed Testing: Challenges with Medical Device Testing
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cybersecurity Compromises, Courtesy of COVID-19

    A Look at the Actual Device Costs for Hospitals

    Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

    FDA Making Progress With Technology and Data Action Plans

    What’s Hot Now in Medtech M&A
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    MW Life Sciences

    Concise Engineering

    FUTEK Advanced Sensor Technology Inc.

    Unicep

    Spectrum Plastics Group
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Grant Funding Works and How It Can Help

    Refurbished Medical Equipment Testing and Certification Under the NEC

    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Unicep

    Medbio LLC

    Medicoil

    PTI Engineered Plastics Inc.

    Forefront Medical Technology
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Funding Tips to Help Medtech Startups Cross the ‘Valley of Death’

    ...

    Funding Tips to Help Medtech Startups Cross the ‘Valley of Death’
    Related CONTENT
    • The 2019 Top 30 Global Medical Device Companies
    • 2. Johnson & Johnson
    • Verb Surgical Appoints New CEO
    • Hologic Partners with MagView to Develop Unifi EQUIP Solution
    • Mobile App Notifies Patients, Caregivers, and Nurses of Medical Device Recalls
    David J. Dykeman, Co-chair, Global Life Sciences & Medical Technology Group, Greenberg Traurig LLP 07.30.19
    Bringing innovative medical technology to market today is as complex and competitive as it’s ever been for entrepreneurs and startups. One of the major hurdles for any early-stage medtech company is funding product development, and the venture capital sector has grown increasingly cautious.

    According to a MoneyTree report from PricewaterhouseCoopers and CB Insights, venture capital (VC) firms invested more than $2.9 billion in medical device companies in 2018, a slight increase from the $2.8 billion raised in 2017. Despite the modest uptick, the bar for new investments has been raised. Many VCs are waiting to invest until a device achieves sufficient safety and efficacy evidence, or until regulatory approval and reimbursement have been secured. In fact, over the last two years, 78 percent of medtech VC investment has gone to later stage deals (Series B+), with many companies raising commercialization rounds after FDA approval.1 In 2018, ophthalmology and neurology devices each had four VC deals valued over $150 million. The neurology deals were Series D or later, and six of the eight deals were commercial stage.1

    Faced with this financing challenge, early-stage medtech companies need to get creative and cast their nets widely for new sources of funding. Non-VC sources of financing are gaining popularity and providing medtech entrepreneurs with more choices than previously available.

    Seed Investments Can Help Launch a Startup
    Seed investment from angel investors, incubators, and accelerators can help startups move from an idea to proof of concept, and in the process, begin to de-risk the technology. Seed investment can reduce the amount future investors might need to invest to move new products through FDA approval and commercialization. Seed stage investment often takes the form of convertible notes or interest-bearing loans.

    Seek Non-Dilutive Funding
    Non-dilutive funding includes grants, awards, prizes, or contracts that do not require giving up any equity in the company. Sources of non-dilutive funding include the government, nonprofit entities, or charitable foundations.

    Government Grants: Various federal government agencies award grants and/or contracts to support medtech research and development, including the National Institutes of Health, National Science Foundation, Department of Defense, and Department of Energy. Some grants are awarded for groundbreaking science, while many federally funded research grants are directed toward specific diseases, organs, or stages of life. State agencies often give grants to companies located in economic development zones or that move to the state. One challenge with government grants is that startups need capital quickly, while government grant cycles move slowly, often taking six to 12 months.2

    America’s Seed Fund: The Small Business Innovation Research Program (SBIR) and the Small Business Technology Transfer Program (STTR), known as “America’s Seed Fund,” are the world’s largest source of non-dilutive, early-stage seed capital. Nearly 5,000 small businesses receive more than $2.5 billion in U.S. federal government grants and contracts to help them conduct the R&D needed to develop and bring high-tech products to market through the SBIR. Sponsored by various government agencies, SBIR grants can help bridge the period between the end of federally funded research and early-stage investment from angel or seed investors. SBIR eligibility requirements are straightforward—the business must be for-profit, have less than 500 employees, be independently owned, located principally in the U.S., and the principal researcher must be a company employee.

    Disease Foundations: Nonprofit disease foundations harness the collective power of the public, private, and academic sectors, fostering collaborations and serving as incubators. Disease foundations can move rapidly and have the flexibility to fund high-risk pilot studies outside the industry roadmap. Disease foundations can inspire follow-on funding from the government, incentivize larger companies to partner sooner, and engage experts with extensive experience in the regulatory process to create a well-defined strategy toward FDA approval. Disease foundations can provide philanthropic support for additional clinical trials and data collection to ensure that FDA-approved treatment options are covered by insurance companies and become broadly available to patients. The investment is also non-dilutive, since foundations typically do not take equity in the startup.

    Increased Corporate VC Interest
    The last decade has seen a dramatic rise in large medtech and life science companies creating venture funds to invest in promising early-stage medical technologies that align with industry giants. These company-based investment funds have stepped in to fill the funding gap and help early-stage medtech companies cross the valley of death. In the last few years, large medical companies have been competing in the race to acquire private medical device companies in the neurological, surgical, orthopedic, and cardiovascular spaces.

    Some recent examples of strategic investments by major players in early-stage companies include:
    • Third Pole Therapeutics, a company developing and delivering cardio-pulmonary therapies, announced a collaboration in March (2019) with Actelion Pharmaceuticals Ltd., a Janssen pharmaceutical company of Johnson & Johnson. The collaboration combines the resources and expertise of one of the largest and most respected healthcare companies to Third Pole’s platform technology, capable of expanding access to potentially lifesaving inhaled nitric oxide (iNO) therapy worldwide.3
    • In May 2019, Techsomed, an Israeli developer of ultrasound-based monitoring systems for thermal ablation procedures, raised $2.6 million—led by Johnson & Johnson Innovation—for obtaining regulatory approval of BioTrace, Techsomed’s real-time predictive imaging system for thermal ablation.4
    • In August 2018, Boston Scientific Corp. acquired Veniti Inc., which developed the Vici Venous Stent System for treating venous obstructive disease. In 2016, Boston Scientific invested in Veniti for 25 percent ownership. The transaction price for the remaining ownership stake included $108 million up-front cash, and up to $52 million in payments contingent upon FDA approval.5
    • In March 2018, Pear Therapeutics inked a deal with Novartis to develop digital therapeutics for multiple sclerosis and schizophrenia.6 In January this year, Novartis participated in a $64 million Series C financing of Pear, led by investment firm Temasek.7

    In addition to traditional sectors such as cardiovascular and orthopedics, medtech investments are being driven by new technologies in high demand, such as mobile health, big data, robotics, and artificial intelligence. As mobile health continues to become more ubiquitous, digital and mobile health solutions are becoming increasingly important to traditional medical device companies as investment, partnership, and acquisition targets.

    Patents Attract Funding
    A strategic patent portfolio protects a company’s core technology, which in turn helps secure funding and establishes a competitive market advantage. A recent study found a startup has about a 2.5 times greater chance of achieving success within 10 years of VC investment if it holds patents before the investment.

    Patents are extremely important for medtech companies in all stages. For early-stage companies, patents are often the only way for investors to place a value on a company’s technology before regulatory approval. In this way, patents make up a significantly greater portion of enterprise value for early-stage medtech firms than for other startups. As a company grows, patents become the currency to secure financing through venture capital or private equity investment. Patents can also lead to collaborations, joint ventures, and licenses with strategic partners.

    For early-stage medtech companies, the key is to develop a strategic patent portfolio that has comprehensive patent coverage around its innovations. The core technology must have adequate patent protection to provide flexibility and room to operate in a desirable market. Companies should file one or a series of patent applications providing the broadest possible patent protection to cover the company’s core technology. To obtain broad patent protection, a medtech company should consider both current and future business objectives and contemplate ways that competitors may attempt to design around its patents.

    Tips to Attract Investment
    Emerging medtech firms that have developed value-driven patent portfolios can maximize opportunities for investment and partnering deals. Besides building a strategic patent portfolio, early-stage medtech companies should consider the following tips to become attractive targets for investment.

    Focus on innovation:  Early-stage companies can sometimes act as outsourced R&D laboratories for larger players. Investors desire access to next-generation technology that disrupts medtech markets, even if regulatory approval is years away. 

    Think long-term: Early-stage firms should plan for investment and partnering deals years in advance. Larger medical device companies are concerned about limiting risk and often monitor a product for years to get comfortable with the technology and management team before investing. 

    Start de-risking on day one:  A medtech startup should address its regulatory, intellectual property, and reimbursement strategies from the beginning in lock step with its investment plan and exit strategy.

    Show commercial potential: Strong initial sales or adoption in hospitals and clinics demonstrates the commercial potential of a new medical technology.

    Medical technology research and development is fraught with challenges, including cost, time, and regulatory hurdles. As many entrepreneurs have learned, starting and growing a medtech company is a time-consuming and difficult process, but with careful planning that includes a strategic patent portfolio, innovators can thrive in the market. Seed stage funding, non-dilutive grants, and investment from strategics can help medtech companies cross the funding “valley of death” until the right time for VC investment. 

    References
    1. http://bit.ly/mpo190750 [PDF]
    2. http://bit.ly/mpo190751
    3. http://bit.ly/mpo190752
    4. http://bit.ly/mpo190753
    5. http://bit.ly/mpo190754
    6. http://bit.ly/mpo190755
    7. http://bit.ly/mpo190756


    David J. Dykeman, a registered patent attorney with over 20 years of experience in patent and intellectual property law, is co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group. He can be reached at dykemand@gtlaw.com or at (617) 310-6009.
    Related Searches
    • acquisition
    • clinical trials
    • ultrasound
    • organs
    Suggested For You
    The 2019 Top 30 Global Medical Device Companies The 2019 Top 30 Global Medical Device Companies
    2. Johnson & Johnson 2. Johnson & Johnson
    Verb Surgical Appoints New CEO Verb Surgical Appoints New CEO
    Hologic Partners with MagView to Develop Unifi EQUIP Solution Hologic Partners with MagView to Develop Unifi EQUIP Solution
    Mobile App Notifies Patients, Caregivers, and Nurses of Medical Device Recalls Mobile App Notifies Patients, Caregivers, and Nurses of Medical Device Recalls
    CarThera Receives FDA Approval for Phase 1/2a Trial in Glioblastoma CarThera Receives FDA Approval for Phase 1/2a Trial in Glioblastoma
    Mike on Medtech: Beyond 510(k)/PMA—De Novo 101 Mike on Medtech: Beyond 510(k)/PMA—De Novo 101
    FDA Warning: Potential Cybersecurity Concerns with Certain Medtronic Insulin Pumps FDA Warning: Potential Cybersecurity Concerns with Certain Medtronic Insulin Pumps
    Eon FR Receives FDA Clearance Eon FR Receives FDA Clearance
    FDA Shares Progress on Efforts to Increase Transparency in Medical Device Reporting FDA Shares Progress on Efforts to Increase Transparency in Medical Device Reporting
    Cook Recalls PTA Balloon Catheters Due to Balloons Bursting Cook Recalls PTA Balloon Catheters Due to Balloons Bursting
    Mike on Medtech: The NYT Editorial Board Statement Mike on Medtech: The NYT Editorial Board Statement
    BRAINBox BRAINBox's Traumatic Brain Injury Test Wins Breakthrough Status
    J&J J&J's Ethicon Acquires Takeda's TachoSil Surgical Patch for $400M
    Massachusetts Medical Device Development Center Names $200K Challenge Winners Massachusetts Medical Device Development Center Names $200K Challenge Winners

    Related Columns

    • Software & IT
      Cybersecurity Compromises, Courtesy of COVID-19

      Cybersecurity Compromises, Courtesy of COVID-19

      As the healthcare industry focused its energies last year on battling SARS-CoV-2, cybercriminals used the distraction to their advantage.
      Michael Barbella, Managing Editor 03.04.21

    • A Look at the Actual Device Costs for Hospitals

      A Look at the Actual Device Costs for Hospitals

      According to a 2018 clinical journal article, U.S. hospitals spent approximately $200 billion on medical devices.
      Maria Shepherd, President and Founder, Medi-Vantage 03.04.21

    • Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

      Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

      For small businesses, trade shows are a critical part of developing new business as well as maintaining contacts.
      Dawn A. Lissy, Founder & President, Empirical 03.04.21


    • FDA Making Progress With Technology and Data Action Plans

      FDA Making Progress With Technology and Data Action Plans

      There is an urgent need to get advanced technologies into the healthcare ecosystem, but all products must first get regulatory approval.
      Alan Rencher, Vice President, Engineering, MasterControl 03.04.21

    • What’s Hot Now in Medtech M&A

      What’s Hot Now in Medtech M&A

      Every M&A cycle in the life sciences/medtech sector fosters exciting deals that interestingly impact the industry in both the short and long term.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 03.04.21

    • Software & IT
      Three Ways to Fast-Track the Total Product Lifecycle

      Three Ways to Fast-Track the Total Product Lifecycle

      Here are three ways leaders including Alcon, Baxter Healthcare, Boston Scientific, Epredia, and Illumina are driving innovation in medtech.
      Seth Goldenberg, Ph.D., Vice President, MedTech, Veeva Systems 03.04.21


    • Materials
      Role and Benefits of Plastics in the COVID-19 Vaccine Rollout

      Role and Benefits of Plastics in the COVID-19 Vaccine Rollout

      With some estimating the U.S. needs at least 850 million syringes for every person to receive the vaccine—plastics will play a significant role.
      Josh Blackmore, Global Healthcare Manager, M. Holland Company 03.03.21

    • R&D & Design
      Six Questions to Consider in Developing a Home Healthcare Device

      Six Questions to Consider in Developing a Home Healthcare Device

      These design decisions stem from questions relative to in-home use and 60601-1-11 compliance.
      Rachael Scott, Lead Electrical Engineer, Key Tech 03.03.21

    • Digital Health
      Five Themes to Watch as Digital Health Takes Center Stage

      Five Themes to Watch as Digital Health Takes Center Stage

      Here are five themes to watch in the sector, including what life sciences developers and investors should know about the current deal-making landscape.
      Stephen W. Bernstein, Partner, McDermott Will & Emery 03.03.21


    • Surgical
      Rethink Your Medtech ASC Strategy, Part 1

      Rethink Your Medtech ASC Strategy, Part 1

      ASCs have adopted a strategy to focus on predictable, low-risk procedures with lower complication rates in an out-of-hospital setting.
      Maria Shepherd, President and Founder, Medi-Vantage 02.03.21

    • R&D & Design
      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic restrictions may have diminished certain advantages large companies hold over small and mid-sized competitors.
      Dawn A. Lissy, President & Founder, Empirical 02.03.21

    • Tips for Reigniting Your MDR/IVDR Preparation

      Tips for Reigniting Your MDR/IVDR Preparation

      To get the MDR/IVDR preparation ball rolling again, here are four processes to help refocus on achieving compliance with the updated regulations.
      Nicolle Cannon, Founder and CEO, Cannon Quality Group LLC 02.03.21


    • Materials
      Three Major Innovation Opportunities for Biomedical Textiles

      Three Major Innovation Opportunities for Biomedical Textiles

      Biomedical textiles are gaining significant momentum for use in medical devices to facilitate less invasive surgical procedures.
      John Greco, Vice President of Sales, Cortland Biomedical 02.03.21

    • Contract Manufacturing
      Use Vertical Integration to Increase Productivity, Drive Innovation

      Use Vertical Integration to Increase Productivity, Drive Innovation

      The concept of vertical integration is simple: a company combining two or more stages of production that would normally be operated by separate companies.
      Ryan Lipe, Senior Vice President of Sales & Marketing, MGS 02.03.21

    • How to Better Prepare for Regulatory Requests and Minimize Impact

      How to Better Prepare for Regulatory Requests and Minimize Impact

      Pressure to increase efficiency in medical device development has been prevalent over the past year, especially with the intensified regulatory expectations.
      Sandi Schaible, Sherry Parker and Kim Ehman, WuXi AppTec Medical Device Testing 02.03.21


    Trending
    • The Benefits Of Blockchain
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Top 10 Trends In The Medical Device And Equipment Industry
    • Plastikos Medical Begins Phase II Of Expansion
    • Cheetah Medical Introduces Noninvasive Monitoring System
    Breaking News
    • FDA OKs First OTC Home Molecular COVID-19 Test
    • FDA Approves Second Sight's Argus 2s Retinal Prosthesis
    • Cross Border Venture Financing Rose in Final Quarter of 2020
    • Aetna Executive Joins Inogen's Board of Directors
    • Guided Therapeutics Raises $1.1 Million in New Preferred Stock Offering
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Stressed Testing: Challenges with Medical Device Testing
    • Resourceful Resources: Materials Make a Difference During the Pandemic
    • Diagnostic Desperation: A Look at IVD Trends During COVID-19
    • Digitize Your QMS via an Enterprise Cloud Platform
    • Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Diets High In Fructose Could Cause Immune System Damage
    Nestlé Acquires Premium Water Brand Essentia
    Kaneka Probiotics Announces Launch of L. plantarum DR7
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President, COO
    Ashland Completes Expansion, Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcoVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs First OTC Home Molecular COVID-19 Test
    FDA Approves Second Sight's Argus 2s Retinal Prosthesis
    Cross Border Venture Financing Rose in Final Quarter of 2020
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sharp Appoints EU Qualified Person
    Baxter Biopharma Solutions Enters Sterile Manufacturing Agreement for Novavax’ COVID-19 Vaccine
    Metrics Contract Services Completes Russian Regulatory Inspection
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    It's International Women's Day—But What Does That Mean?
    e.l.f. Cosmetics and Chipotle Collaborate on Burrito-Inspired Makeup Collection
    Weekly Recap: Sephora Expansion, Ulta Partners with Loop, International Women’s Day & More
    Happi

    Latest Breaking News From Happi

    Cococare Appoints First Woman President
    Ross Highlights Triple Shaft Mixers
    Arm & Hammer Unveils Foot Wipes
    Ink World

    Latest Breaking News From Ink World

    Capital Printing Invests in 2nd Komori Press
    Arna Marketing Adds Canon’s ProStream, VarioPRINT iX Production Inkjet Presses
    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Xeikon details upcoming Xeikon Café TV seminars
    Resource Label Group acquires New England Label
    UV+EB-cured products rated 'easier to recycle'
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Arm & Hammer Launches Foot Wipes
    Kimberly-Clark Names Chief Research and Development Officer
    FPInnovations Develops Biodegradable Mask
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Australia Clears Conformis' iTotal PS Knee Replacement System
    Colfax Decides to Divide Its Businesses
    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research
    Wearable Patch Market to Reach $27.8 Billion by 2027: Allied Market Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login